Rosetta Biosoftware today announced that Mendel Biotechnology licensed the Rosetta Resolver® system. The Rosetta Resolver system is an enterprise-wide gene expression data analysis system designed to meet the scientific and business requirements of a global gene expression research effort by providing quality data analysis within a highly scalable and customizable analytical software solution.

"Mendel Biotechnology is a leader in plant functional genomics research and recognizes the growing importance that global transcript profiling data will have upon this field," said Bradley K. Sherman, Director of Bioinformatics of Mendel Biotechnology. "The Rosetta Resolver system will allow us to effectively analyze and mine these data to determine the function of important plant genes and to develop plants and plant-derived products that improve the quality of human life."

"Rosetta Biosoftware is proud to provide Mendel Biotechnology with a system that will accelerate its research and have an impact on its core business of plant genetics research," said Douglas E. Bassett, Jr., Ph.D., vice president and general manager of Rosetta Biosoftware. "Working in collaboration with customers such as Mendel Biotechnology, Rosetta Biosoftware will continue to extend the Rosetta Resolver system to meet the future needs of cutting-edge gene expression research."

The Rosetta Resolver system is developed by Rosetta Biosoftware and is distributed exclusively by Agilent Technologies, Inc.

About the Rosetta Resolver System

The Rosetta Resolver system is a high-capacity data storage, retrieval and analysis solution for gene expression data. The system is ideal for life science research organizations that need to assess compound specificity or toxicity, identify new genes or therapeutic targets, or compare and analyze large databases of expression profiles. The Rosetta Resolver system combines flexibility and ease of use with high-performance algorithms to produce an enterprise solution for rapid analysis of gene expression data. The Rosetta Resolver system can accept and analyze data from a wide variety of expression profiling formats, including Agilent DNA microarrays, and applies Rosetta Biosoftware's proprietary error models to yield quality statistics for every gene expression measurement within the system. These statistics are automatically leveraged by Rosetta Resolver system analysis tools for optimal results. The system is also highly customizable, and includes a Software Development Kit (SDK) for extension and customization.

In addition to Mendel Biotechnology, other life science research organizations that have licensed the Rosetta Resolver system include many of the top pharmaceutical companies in the world, such as Aventis Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline and Merck & Co., Inc., as well as premier academic institutions such as the Harvard University Center for Genomics Research. Additional information about the Rosetta Resolver system can be found on the Rosetta Biosoftware Web site at www.rosettabio.com. 

About Rosetta Biosoftware

Rosetta Biosoftware is a leading provider of enterprise bioinformatics solutions for life science research. Its enterprise software solutions, including the Rosetta Resolver and Rosetta Luminator gene expression data analysis systems, are designed to empower researchers to accelerate discovery with advanced, scalable, and easy-to-use analysis technology. Rosetta Biosoftware is a business unit of Rosetta Inpharmatics LLC, a wholly-owned subsidiary of Merck & Co., Inc. (NYSE:MRK - News). For more information on Rosetta Biosoftware, please visit www.rosettabio.com.

About Mendel Biotechnology